HOME >> MEDICINE >> NEWS
UCSD researcher wins grant to study colon cancer in African-Americans

The California Cancer Research Program (CRP) of the state Department of Health Services has awarded a physician-scientist at University of California, San Diego (UCSD) a $600,000 grant to conduct a 3-year study of colon cancer in African-Americans.

John Carethers, M.D., assistant professor of medicine at UCSD School of Medicine and member of the UCSD Cancer Center, received the highest score possible in the granting process. There were 92 grants funded out of 302 applications submitted.

With this grant, Carethers and colleagues will study tissue samples from African-American colon cancer patients to determine the incidence and impact of a particular chromosomal abnormality, called microsatellite instability (MSI). This abnormality is associated with colorectal cancer development, particularly the more virulent types. African-Americans seem to suffer from a more aggressive form of the disease compared to whites.

"When compared to statistics for whites, African-Americans have only a slightly higher incidence of colorectal cancer, but they have much higher death rates," said Carethers. "We believe MSI may play an important role."

Preliminary research in Carethers' laboratory has shown that cells with this abnormality do not respond to the widely used chemotherapeutic agent 5-fluoruracil (5-FU). The researchers will now further test this observation by studying the medical records of patients who received 5-FU treatment and whose tissue tested positive for microsatellite instability.

Also, the team will study the genes mutated by microsatellite instability to determine if they might be useful in predicting a given tumor's potential for metastasis.

"The new insights gained from this work may reveal the need for new screening strategies and new chemotherapeutic agents," said Carethers. "In addition, we hope to gain a clearer understanding of tumor formation that will benefit all patients."

Every year, approximately 149,000 people in
'"/>

Contact: Nancy Stringer
nstringer@ucsd.edu
619-543-6163
University of California - San Diego
4-Jun-2000


Page: 1 2

Related medicine news :

1. U of M researcher says Viagra may cause permanent vision loss in some men
2. Indiana University researchers closer to helping hearing-impaired using stem cells
3. Protein that helps skin cancer spread identified by Stanford researchers
4. US life expectancy about to decline, researchers say
5. Gene for age-related macular degeneration discovered by Yale researchers
6. Dartmouth researchers find where musical memories are stored in the brain
7. Columbia researchers receive $3 million to combat genetic killer of infants & toddlers
8. US cancer researchers launch first American-Israeli cancer conference
9. Mayo Clinic researcher calls for improved newborn screening
10. Hard choices: Pitt researcher presents findings on when to accept organ transplants
11. Brain-scanning technologies need standards, according to Stanford researcher

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/10/2016)... IN (PRWEB) , ... February 10, 2016 , ... ... benefits advisory organization, welcomes S.S. Nesbitt as the latest addition to its growing ... has seven other locations throughout the Southeast, from Orlando to Huntsville and in ...
(Date:2/10/2016)... ... ... Armune BioScience signed a definitive agreement with ARCpoint Labs ... the country. Launched in April of 2015, Apifiny is the only cancer specific, non-PSA ... volume exceeded 3,000 tests in 2015. Primary care physicians and urologists have utilized Apifiny ...
(Date:2/10/2016)... ... February 10, 2016 , ... For additional information contact ... , Pioneering book "Better with Age: The Ultimate Guide to Brain Training" by award-winning ... improve memory. The book’s publication date is March 16, 2016. A free review ...
(Date:2/10/2016)... ... February 10, 2016 , ... Everseat has joined the award-winning ... to physicians. The integration will enable Allscripts users to post open appointments to ... mobile app. , The partnership gives Everseat substantial added power to help Allscripts ...
(Date:2/10/2016)... ... ... Workrite Ergonomics this week announced the launch of the Conform Monitor Arm Series, ... was to develop a product from the ground up that would provide the most ... Hulsey, Product Manager for Workrite Ergonomics. “The Conform series features a wide variety ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... BASEL, Switzerland and SAN DIEGO ... Houston , Inc., a global leader in viral gene ... gene therapy treatments for congestive heart failure and other ... to develop a scalable manufacturing process and produce cGMP-grade ... clinical trials. --> ...
(Date:2/10/2016)... Immune Pharmaceuticals Inc. (NASDAQ: IMNP ), ... has filed a patent application directed to the treatment ... --> --> The new invention ... (histamine dihydrochloride) in combination with immune checkpoint inhibitors. The ... of Ceplene and IL-2 therapy in patients with Acute ...
(Date:2/10/2016)... ANGELES , Feb. 10, 2016  Oxis International ... cancer drug, OXS-1550, was described as a "clinical trial ... the drug went into complete cancer remission. ... University of Minnesota Masonic Cancer Center. --> ... University of Minnesota Masonic Cancer Center. --> ...
Breaking Medicine Technology:
Cached News: